|
000
| 02090cam 2200397zi 4500 |
|---|
| 001 | 9.867966 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107162445 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 190204t20172017onc o f000 0 eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-266/2018E-PDF |
|---|
| 245 | 00|aGuidance document : |bquality (chemistry and manufacturing) guidance : new drug submissions (NDSs) and abbreviated new drug submissions (ANDSs). |
|---|
| 246 | 30|aQuality (chemistry and manufacturing) guidance : |bnew drug submissions (NDSs) and abbreviated new drug submissions (ANDSs) |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c[2017] |
|---|
| 264 | 4|c©2017. |
|---|
| 300 | |a1 online resource (vi, 85 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Ligne directrice : qualité (chimie et fabrication) : présentations de drogue nouvelle (PDN) et présentations abrégées de drogue nouvelle (PADN). |
|---|
| 500 | |aCover title. |
|---|
| 500 | |a"Health Products and Food Branch." |
|---|
| 500 | |aIncludes addendum (questions and answers). |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 692 | 07|2gccst|aDrugs |
|---|
| 692 | 07|2gccst|aHealth policy |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |
|---|
| 710 | 1 |aCanada. |bHealth Products and Food Branch. |
|---|
| 775 | 08|tLigne directrice : |w(CaOODSP)9.867968 |
|---|
| 856 | 40|qPDF|s336 KB|uhttps://publications.gc.ca/collections/collection_2019/sc-hc/H164-266-2018-eng.pdf|z(guidance document) |
|---|
| 856 | 40|qPDF|s58 KB|uhttps://publications.gc.ca/collections/collection_2019/sc-hc/H164-266-2018-1-eng.pdf|z(addendum) |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/chemical-entity-products-quality/guidance-document-quality-chemistry-manufacturing-guidance-new-drug-submissions-ndss-abbreviated-new-drug-submissions.html|z(guidance document) |
|---|